| 期刊論文1. | 陳瑋昇、林孝義、黃德豐(20090200)。全身性紅斑性狼瘡腎炎治療的新進展。內科學誌,20(1),40-47。 延伸查詢![new window](/gs32/images/newin.png) | 2. | 王馨慧(2010)。全身性紅斑性狼瘡病人的感染預防。臺灣兒童過敏氣喘及免疫學會學會通訊,11(2),8-9。 延伸查詢![new window](/gs32/images/newin.png) | 3. | 李海紅、吳葉榮、張海云(2010)。應用臨床護理路徑對系統性紅斑狼瘡病人實施健康教育。護理實踐與研究,7(1),5-6。 延伸查詢![new window](/gs32/images/newin.png) | 4. | Barber, C.、Gold, W. L.、Fortin, P. R.(2011)。Infections in the lupus patient: Perspectives on prevention。Curr Opin Rheumatol,23(4),358-365。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) | 5. | Bernknop, A.、Rowley, K.、Bailey, T.(2011)。A review of systemic lupus erythematosus and current treatment options。Formulary,46(5),178-194。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) | 6. | Bertsias, G.、Ioannidis, J. P. A.、Boletis, J.、Bombardieri, S.、Cervera, R.、Dostal, C.(2008)。EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics。Annals of the Rheumatic Diseases,67(2),195-205。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) | 7. | Cancro, M. P.、D'Cruz, D. P.、Khamashta, M. A.(2009)。The role of B lymphocyte stimulator (BLyS) in systemic lupus erythematosus。The Journal of clinical investigation,119(5),1066-1073。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) | 8. | Cleary, B. J.、Källén, B.(2009)。Early pregnancy azathioprine use and pregnancy outcomes。Birth Defects Research Part A: Clinical and Molecular Teratology,85(7),647-654。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) | 9. | Dhanhani, A. M. A.、Gignac, M. A. M.、Su, J.、Fortin, P. R.(2009)。Work disability in systemic lupus erythematosus。Arthritis Care & Research,61(3),378-385。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) | 10. | Hahn, B. H.、McMahon, M. A.、Wilkinson, A.、Wallace, W. D.、Daikh, D. I.、FitzGerald, J. D.、Grossman, J. M.、Ramsey-Goldman, R.(2012)。American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis。Arthritis Care & Research,64(6),797-808。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) | 11. | Han, B.、Bhatia, R.、Traisak, P.、Hunter, K.、Milcarek, B.、Schorr, C.(2013)。Clinical presentations and outcomes of systemic lupus erythematosus patients with infection admitted to the intensive care unit。Lupus,22(7),690-696。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) | 12. | Merrill, J. T.、Neuwelt, C. M.、Wallace, D. J.、Shanahan, J. C.、Latinis, K. M.、Oates, J. C.、Brunetta, P. G.(2010)。Efficacy and safety of rituximab in moderately to severely active systemic lupus erythematosus: The randomized, double blind, phase ii/iii systemic lupus erythematosus evaluation of rituximab trial。Arthritis & Rheumatism,62(1),222-233。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) | 13. | Mok, C. C.、Yap, D. Y. H.、Navarra, S. V.、Liu, Z.-h.、Zhao, M.-h.、Lu, L.、The Asian Lupus Nephritis Network(2013)。Overview of lupus nephritis management guidelines and perspective from Asia。International Journal of Rheumatic Diseases,16(6),625-636。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) | 14. | Morton, M.、Edmonds, S.、Doherty, A.、Dhaygude, A.、Helbert, M.、Venning, M.(2012)。Factors associated with major infections in patients with granulomatosis with polyangiitis and systemic lupus erythematosus treated for deep organ involvement。Rheumatology International,32(11),3373-3382。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) | 15. | Ruiz-Irastorza, G.、Olivares, N.、Ruiz-Arruza, I.、Martinez-Berriotxoa, A.、Egurbide, M. V.、Aguirre, C.(2009)。Predictors of major infections in systemic lupus erythematosus。Arthritis Research & Therapy,11(4),1-8。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) | 16. | Stohl, W.、Hiepe, F.、Latinis, K. M.、Thomas, M.、Scheinberg, M. A.、Clarke, A.、Groups, B.-S.(2012)。Belimumab reduces autoantibodies, normalizes low complement levels, and reduces select B cell populations in patients with systemic lupus erythematosus。Arthritis & Rheumatism,64(7),2328-2337。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) | 17. | Wheeler, T.(2010)。Systemic lupus erythematosis: The basics of nursing care。British Journal of Nursing,19(4),249-253。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) | 18. | Yazdany, J.、Trupin, L.、Kaiser, R.、Schmajuk, G.、Gillis, J. Z.、Chakravarty, E.、Schwarz, E. B.(2011)。Contraceptive counseling and use among women with systemic lupus erythematosus: A gap in health care quality?。Arthritis Care & Research,63(3),358-365。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) | 研究報告1. | 黃朱貝、白玉珠、黃慧雯、康平靜、陳玉萍、張于慧、林柏瑤、邱詩書、王佳雯、黃詩涵、吳珮蓉、彭秀榮(2012)。紅斑性狼瘡病人運動照護指引之建立與評值 (計畫編號:2011-09-016IC)。 延伸查詢![new window](/gs32/images/newin.png) | 學位論文1. | 彭秀榮(2012)。全身性紅斑性狼瘡患者的症狀困擾、不確定感、復原力、社會支持與健康生活品質之關係探討(碩士論文)。國立臺北護理健康大學。 延伸查詢![new window](/gs32/images/newin.png) | 其他1. | Richman, S.(2013)。Systemic lupus erythematosus and pregnancy complications,http://search.ebscohost.com/login.aspx?direct=true&db=nrc&AN=T701328&lang=zh-tw&site=nrclive。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) | 2. | Richman, S.,Schub, T.(2012)。Systemic lupus erythematosus,http://search.ebscohost.com/login.aspx?direct=true&db=rzh&AN=5000002210&lang=zh-tw&site=nrc-live。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) | |